Cargando…
Efficacy and Safety of 120-W Thulium:Yttrium-Aluminum-Garnet Vapoenucleation of Prostates Compared with Holmium Laser Enucleation of Prostates for Benign Prostatic Hyperplasia
BACKGROUND: This study compared the efficacy and safety between 120-W thulium:yttrium-aluminum-garnet (Tm:YAG) vapoenucleation of prostates (ThuVEP) and holmium laser enucleation of prostates (HoLEP) for patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). MET...
Autores principales: | Hong, Kai, Liu, Yu-Qing, Lu, Jian, Xiao, Chun-Lei, Huang, Yi, Ma, Lu-Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834003/ https://www.ncbi.nlm.nih.gov/pubmed/25836607 http://dx.doi.org/10.4103/0366-6999.154282 |
Ejemplares similares
-
Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia
por: Chung, Jae Seung, et al.
Publicado: (2020) -
A prospective, randomized comparison of a 1940 nm and a 2013 nm thulium: yttrium–aluminum–garnet laser device for Thulium VapoEnucleation of the prostate (ThuVEP): First results
por: Tiburtius, Christian, et al.
Publicado: (2015) -
Outcomes following Thulium vapoenucleation of large prostates
por: Pearce, Shane M., et al.
Publicado: (2016) -
Influence of Prostate Cancer on Thulium Vapoenucleation of the Prostate—A Multicentre Analysis
por: Lamersdorf, Tobias, et al.
Publicado: (2023) -
Technical Aspects of Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Kim, Myong, et al.
Publicado: (2013)